MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "1-Methyl-4-phenylpyridinium (MPP+)"

  • MDS Virtual Congress 2020

    Abrogation of neuroinflammation and behavioural deficit by Chlorogenic acid and Tinosporia cordiofolia in MPTP-Induced Parkinsonian mice model via suppressing NF-κB pathway

    D. Singh, M. Singh (Allahabad, India)

    Objective: The current study was designed with the aim to investigate the anti-neuroinflammatory activity of chlorogenic acid (CGA) and ethanolic extract of Tinospora cordifolia (TPE)…
  • MDS Virtual Congress 2020

    4-Chlorokynurenine inhibits L-Dopa-induced dyskinesias in non-human parkinsonian primates

    T. Di Paolo, M. Bourque, R. Snodgrass (Quebec City, QC, Canada)

    Objective: This study investigated the antidyskinetic activity of 4-chlorokynurenine (AV-101) in parkinsonian monkeys with L-Dopa-induced dyskinesias. Background: The common treatment for Parkinson’s disease (PD) is L-Dopa…
  • MDS Virtual Congress 2020

    Perillyl alcohol restores mitochondrial dysfunction and abridge NLRP3 inflammasomes activation in in-vitro and in-vivo model of Parkinson’s disease

    P. Panda, S. Ahmed, V. Naidu (Kamrup, India)

    Objective: Parkinson's disease (PD) affects around 2-3% population of age greater than 65 and is the second most common neurogenerative disorder. The molecular mechanism underpinning…
  • MDS Virtual Congress 2020

    Activated microglia contribute to MPTP-induced impairment of cardiovascular function

    X. Liu, B. Wei, Q. Sun, Q. Bi, X. Shen, P. Shi (Hangzhou, China)

    Objective: To investigate the contribution of microglia in MPTP-induced loss of adrenergic neurons and impairment of cardiovascular function. Background: Parkinson’s disease (PD) is a neurodegenerative…
  • MDS Virtual Congress 2020

    Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

    S. Khudayarova, G. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the clinical and neurological features of the course of parkinsonism in chronic renal disease. Background: Under our supervision were 30 patients with…
  • MDS Virtual Congress 2020

    Andrograholide protect microglial activation via inhibiting mitochondrial ROS generation and NLRP3 inflammasome activation in in-vitro and in-vivo model of Parkinson’s disease

    S. Ahmed, V. Naidu (Kamrup, India)

    Objective: Parkinson's disease (PD) is a distressing neurodegenerative disorder effecting nearly 2-3% of the total population greater than 65 years old . Several mechanisms have…
  • MDS Virtual Congress 2020

    Calcitriol Treatment Attenuates Dopaminergic Neurodegeneration in Mice Model of Parkinson’s Disease

    JJ. Hu, T. Wang (Wuhan, China)

    Objective: To investigate the role and mechanism of Calcitriol (1,25-dihydroxyvitamin D3) in Parkinson's mice and cell model Background: Parkinson's disease (PD) is a neurodegenerative disorder…
  • MDS Virtual Congress 2020

    Long-term effect of deep brain stimulation in a monkey model of Parkinson’s disease with L-Dopa–induced dyskinesias

    M. Bourque, S. Carrondo-Cottin, M. Parent, L. Cantin, B. Gosselin, M.E Tremblay, T. Di Paolo (Quebec City, QC, Canada)

    Objective: This study investigated the effect of long-term deep brain stimulation (DBS) of the subthalamic nucleus (STN) on motor behavior in a parkinsonian monkey treated…
  • 2019 International Congress

    Increased vesicular monoamine transporter alleviate MPTP-induced impairment of neurogenesis

    K. Ma, G. Zhang, C. Han, X. Guo, Y. Xia, F. Wan, L. Kou, S. Yin, L. Liu, N. Xiong, J. Huang, T. Wang (Wuhan, China)

    Objective: In this study, we employed vesicular monoamine transporter 2–overexpressing mice (VMAT2-HI) to investigate the influence of increased vesicular storage of catacholamines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced…
  • 2019 International Congress

    Improving neuroprotective effects of resveratrol by brain targeting through chitosan glutamate nanoparticles in MPTP induced parkinsonism

    M-R. Rahman, V-K. Kumar (Allahabad, India)

    Objective: The aim of the present study was to develop and evaluate the neuroprotective effects of resveratrol (RV) using chitosan glutamate nanoparticles (RV-CG-NPs) in a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley